Weining Wu

Nanjing, 210006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

RBMS1 promotes the proliferation of glioma cells via regulation of the c-Myc-SSH1 axis.

RBMS1 promotes the proliferation of glioma cells via regulation of the c-Myc-SSH1 axis.

Journal: Biochemical and biophysical research communications
Published: December 12, 2024

The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.

The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.

Journal: Journal of experimental & clinical cancer research : CR
Published: November 14, 2018

MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin.

MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin.

Journal: Biochemical and biophysical research communications
Published: November 06, 2018

Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.

Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.

Journal: Cancer letters
Published: March 08, 2018

MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Journal: American journal of translational research
Published: August 01, 2017

EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma.

EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma.

Journal: Oncotarget
Published: June 28, 2017

MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12.

MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 17, 2017

Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma.

Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma.

Journal: Oncogene
Published: April 19, 2017

The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells.

The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells.

Journal: Oncotarget
Published: April 18, 2017

Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma.

Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma.

Journal: Neuro-oncology
Published: April 04, 2017

RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis.

RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis.

Journal: Oncology letters
Published: April 03, 2017

MicroRNA-1301 inhibits proliferation of human glioma cells by directly targeting N-Ras.

MicroRNA-1301 inhibits proliferation of human glioma cells by directly targeting N-Ras.

Journal: American journal of cancer research
Published: February 18, 2017
Showing 1-12 of 20

Last Updated: 09/26/2026